[HTML][HTML] Pathogenesis of Lassa fever in cynomolgus macaques

LE Hensley, MA Smith, JB Geisbert, EA Fritz… - Virology journal, 2011 - Springer
LE Hensley, MA Smith, JB Geisbert, EA Fritz, KM Daddario-DiCaprio, T Larsen, TW Geisbert
Virology journal, 2011Springer
Background Lassa virus (LASV) infection causes an acute and sometimes fatal hemorrhagic
disease in humans and nonhuman primates; however, little is known about the development
of Lassa fever. Here, we performed a pilot study to begin to understand the progression of
LASV infection in nonhuman primates. Methods Six cynomolgus monkeys were
experimentally infected with LASV. Tissues from three animals were examined at an early-to
mid-stage of disease and compared with tissues from three animals collected at terminal …
Background
Lassa virus (LASV) infection causes an acute and sometimes fatal hemorrhagic disease in humans and nonhuman primates; however, little is known about the development of Lassa fever. Here, we performed a pilot study to begin to understand the progression of LASV infection in nonhuman primates.
Methods
Six cynomolgus monkeys were experimentally infected with LASV. Tissues from three animals were examined at an early- to mid-stage of disease and compared with tissues from three animals collected at terminal stages of disease.
Results
Dendritic cells were identified as a prominent target of LASV infection in a variety of tissues in all animals at day 7 while Kupffer cells, hepatocytes, adrenal cortical cells, and endothelial cells were more frequently infected with LASV in tissues of terminal animals (days 13.5-17). Meningoencephalitis and neuronal necrosis were noteworthy findings in terminal animals. Evidence of coagulopathy was noted; however, the degree of fibrin deposition in tissues was less prominent than has been reported in other viral hemorrhagic fevers.
Conclusion
The sequence of pathogenic events identified in this study begins to shed light on the development of disease processes during Lassa fever and also may provide new targets for rational prophylactic and chemotherapeutic interventions.
Springer